DelveInsight’s Chemiluminescence Immunoassay Market Insights report provides the current and forecast market analysis, ...

In particular, the company developed its Lumipulse system, which was one of the world’s first fully automated chemiluminescent enzyme immunoassay (CLEIA) instruments when it was launched in 1992.

The US Food and Drug Administration (FDA) has cleared Revvity’s automated chemiluminescence-based immunoassay (ChLIA) test for free testosterone. The authorisation by the agency marks the first ...

The ABBOTT PRISM System is an automated immunoassay analyzer designed to perform Chemiluminescent immunoassay (ChLIA) technology. The ABBOTT PRISM performs batch/continuous access and STAT ...

These chemiluminescent, no-wash assays are ideally ... advantageously with conventional enzyme-linked immunosorbent assay (ELISA). You have full access to this article via your institution.

Revvity, Inc. RVTY announced the receipt of the FDA’s 510(k) clearance for EUROIMMUN’s automated chemiluminescence-based immunoassay (ChLIA) test for free testosterone. Per management ...

The appearance of insulin glargine in the fetal circulation was analyzed by a chemiluminescence immunoassay. Insulin glargine (Lantus; Aventis Pharmaceuticals, Bridgewater, NJ) is a long-acting ...

Xpress-Screen combines Tropix Inc.'s chemiluminescence technology with the well-known and FDA-approved Digene Hybrid Capture ® system for detection of DNA-RNA hybrids. This assay can measure a two- to ...

Immunoprotein is an immunologically active protein, which provides immunity against pathogenic organisms or substances. These proteins form the integrated body system of tissues, organs, cells, or ...